Biotech Progenity Inc. priced its initial public offering on Friday at $15 share, the midpoint of its price range. The company sold 6.8 million shares to raise $100.5 million. The share will start trading later Friday on Nasdaq under the ticker symbol "PROG." Piper Sandler, Wells Fargo, Baird, Raymond James and BTIG were underwriters on the deal. Proceeds will be used for R&D and for working capital and general corporate purposes.